Fintel reports that on January 31, 2025, Stifel upgraded their outlook for C.H. Robinson Worldwide (NasdaqGS:CHRW) from Hold ...

Kahuna Workforce Solutions, a leading skills and competency management SaaS platform, today announced financing from Stifel Bank, an affiliate of Stifel Financial Corp., a global diversified financial ...

Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.

Stifel lowered the firm’s price target on Intel (INTC) to $21 from $25 and keeps a Hold rating on the shares. Q4 results were above management ...

Q4 2024 Earnings Call Transcript January 29, 2025 Stifel Financial Corp. beats earnings expectations. Reported EPS is $2.23, ...

While total segment revenue declined 6.6% year-over-year due to weak truckload (TL) demand and lower rates, gross margins ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $89.57 which represents a decrease of $-0.29 or -0.32% from the prior close of $89.86. The stock opened at $90.11 and touched a low of ...

Over the past five years, Stifel has hired 450 advisors, with a cumulative trailing 12-month production of more than $350 million, according to CFO Marischen. That has driven the wealth division’s ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

The natural beauty of West Virginia will be celebrated both musically and visually in the Wheeling Symphony Orchestra’s upcoming performance, “Nature. Beauty.” Set for 2 p.m., Feb. 8, at the Capitol ...

CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced Getinge off the U.S. market in 2015.

Shares of Stifel Financial were moving higher after it reported fourth-quarter adjusted earnings that beat Wall Street ...